Page 16 - Stroke Statistics News Today

/PRNewswire/ -- According to Coherent Market Insights, the home healthcare market is expected to be valued at US$ 279,541.7 million in 2019, and is projected...

SEATTLE, Oct. 13, 2021 /PRNewswire/ -- According to Coherent Market Insights, the home healthcare market is expected to be valued at US$ 279,541.7 million in 2019, and is projected to exhibit

Patient-friendly alternative to continuous IV administration – proven safety and efficacyTargeting orphan, late-stage heart failure indication with high...

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

Digital Therapeutics (DTx) Market Bigger Than Expected | Better Therapeutics, Pear Therapeutics, Wellthy Therapeutics, Mindstrong Health

Digital Therapeutics (DTx) Market Bigger Than Expected | Better Therapeutics, Pear Therapeutics, Wellthy Therapeutics, Mindstrong Health

Active Implantable Medical Devices Market is expected to reach US$ 22,096.9 Mn with a CAGR of 7.9% from 2018-2025 iCrowd Newswire 01 Jul 2021, 11:57 GMT+10 According to The Insight Partners market research study titled Active Implantable Medical Devices Market to 2025 – Global Analysis and Forecasts by Product and End User, the global active implantable medical devices market was valued at US$ 22,096.9 Mn in 2017 and is estimated to reach US$ 39,026.9 Mn by 2025. The market is estimated to gr...

Surgical Gloves Market is expected to reach US$ 5,028.07 million With CAGR of 10.3% from 2020 to 2027 iCrowd Newswire 01 Jul 2021, 11:57 GMT+10 According to our new market research study on "Surgical Gloves Market to 2027 – Global Analysis and Forecast – by product, applications and end user," the market is expected to reach US$ 5,028.07 million by 2027 from US$ 2,292.03 million in 2019. The market is estimated to grow with a CAGR of 10.3% from 2020 to 2027. The report highlights trends pre...

and Chair of the Steering Committee for SOS-AMI, commented: "P2Y 12 receptor antagonists have been used in the treatment of millions of patients globally, and their safety and efficacy profiles are well established. Despite the success of chronic treatment with this class and other effective interventions, patients are still suffering recurrent heart attacks. The idea for patients to self-inject early in the onset of symptoms is truly innovative. The subcutaneous route of administration could ...

Research Highlights: Race, age, income and health insurance status are factors in the distance patients must travel to reach the nearest certified stroke...